categories. It offers its products in various dosage forms, including tablets and capsules,
creams and topicals, ointments, liquids, and injectables.
The company has licenses to manufacture 30 products and approximately
300 generic drugs and product formulations for distribution. It offers generic pharmaceutical
products in the areas of anti-arthritic/analgesics, anticancer drugs, antifungals, anti-infectives,
cardiovascular agents, central nervous system, dermatological, gastrointestinal and
respiratory drugs, biotechnology products, hormones, anesthetics, antidiabetics, antiemetics,
dermatologicals, immunosuppressive agents, ophthalmic drugs, and treatments for benign
The company markets its products directly and through partner alliance agreements to
drug wholesalers, mass merchandisers, warehousing chain drug stores, and mail-order
pharmacies primarily in the Far East, Africa, European Union, Southeast Asia, and Latin America. SOHM, Inc. was founded in 2005 and is headquartered in Buena Park, California.
India has a significant share in the global generics market and is ranked third in the world.
Three factors favoring the company’s manufacturing hub in India are a strong marketing set up,
low prices and the advantage of using the English language. With domestic drug sales of almost
$5 billion, Indian companies have also developed a considerable service industry for the
global pharmaceutical market.
Emerging Markets – Focus on High Growth
SOHM’s Growth Strategy – Emerging Markets Leader
Rapidly responding to customers’ most significant needs by – among others—broadening SOHM’s
Products and Services
and are typically sold under their chemical names at prices substantially
below those of the brand-name pharmaceuticals.
Generics are required to meet similar governmental regulations as their brand-name equivalents
and must receive regulatory approval prior to their sale in any given country.
Generic pharmaceuticals are benefiting from increasing awareness and acceptance on the part of
consumers, physicians and pharmacists globally.
Factors contributing to this increased awareness are the passage of legislation permitting or encouraging
substitution and the publication by regulatory authorities of lists of
equivalent pharmaceuticals, which provide physicians and pharmacists with generic alternatives.
SOHM believes that these factors, together with an aging population and a corresponding increase in
healthcare costs, as well as the large number of branded products losing patent protection over the
coming years, should lead to continued global expansion of the generic pharmaceuticals market.
Friday, January 27, 2012
Friday, January 20, 2012
Wednesday, November 23, 2011
Monday, November 14, 2011
A Message from the President of SOHM
Thursday, November 3, 2011
Monday, September 12, 2011
Friday, August 5, 2011
Tuesday, August 2, 2011
Mr. Shailesh Shah , 46
Chairman, Chief Exec. Officer, Pres, Chief Exec. Officer of US, India & Global Operations
and Pres of US, India & Global Operations
Mr. L. Dee Hall , 66
Chief Operating Officer
Ms. Swati Shah ,
VP, Sec., Treasurer and Director
Mr. Sanjiv Bosamia ,
Chief Exec. Officer of Dermatology and Cosmeceutical Division
Mr. Shaunak Parikh ,
VP of Operations
Phone: 1 (714) 522-6700
Fax: 1 (714) 523-4329
As Always: Our Number 1 Priority is to educate. Penny stocks are very volatile, Always do your own Due Diligence
Sources: otcmarket.com, www.bloomberg.com, www.finance.yahoo.com, www.businessweek.com (these are only sources and not always up to date) This alert brought to you by SizzlingStockPicks
Follow Us on Twitter https://twitter.com/#!/SizzlinStockPix
Follow Us on Facebook http://www.facebook.com/groups/SizzlingStockPicks/